CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
FLUTCORE is developing a universal vaccine for influenza A virus that targets multiple subtypes using a novel virus-like particle platform. The project aims to enhance vaccine effectiveness and accessibility by focusing on invariant antigens and rigorous testing in animal models before clinical trials.
FLUTCORE will develop a novel universal influenza A virus (IAV) vaccine based on the tandem core vaccine platform.
Recent influenza pandemics have emphasized the urgent need for better vaccines that are reactive with multiple IAV subtypes and that are no longer dependent on intimate knowledge of the prevalent virus.
We propose to replace the existing seasonal IAV vaccine with a virus like particle (VLP) carrying several invariant “universal” influenza antigens.
Previous attempts to use these tar…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, Leeds
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, LONDON
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
